Loblaw Companies Limited (TSE:L – Get Free Report) has been given an average recommendation of “Moderate Buy” by the eight brokerages that are currently covering the company, Marketbeat Ratings reports. Two equities research analysts have rated the stock with a hold recommendation and six have issued a buy recommendation on the company. The average 1 year target price among analysts that have updated their coverage on the stock in the last year is C$199.25.
A number of analysts have recently weighed in on the company. BMO Capital Markets upped their target price on Loblaw Companies from C$220.00 to C$230.00 and gave the company a “market perform” rating in a research report on Friday, July 25th. National Bankshares cut their target price on Loblaw Companies from C$242.00 to C$60.00 in a research report on Wednesday, August 20th. Desjardins upped their price objective on Loblaw Companies from C$230.00 to C$235.00 and gave the stock a “hold” rating in a research report on Friday, July 25th. Royal Bank Of Canada upped their price objective on Loblaw Companies from C$234.00 to C$267.00 in a research report on Monday, July 21st. Finally, TD Securities upped their price objective on Loblaw Companies from C$245.00 to C$250.00 and gave the stock a “buy” rating in a research report on Friday, July 25th.
Loblaw Companies Stock Performance
Loblaw Companies Announces Dividend
The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, October 1st. Investors of record on Wednesday, October 1st were given a dividend of $0.5643 per share. This represents a $2.26 annualized dividend and a dividend yield of 4.0%. The ex-dividend date was Monday, September 15th. Loblaw Companies’s dividend payout ratio is currently 26.06%.
Loblaw Companies Company Profile
Loblaw is one of Canada’s largest grocery, pharmacy, and general merchandise retailers, operating the most expansive store footprint in Ontario and maintaining sizable presences in provinces like Quebec and British Columbia. Key grocery banners include Loblaw, No Frills, and Maxi, while its pharmaceutical operations are the product of its 2014 acquisition of Shoppers Drug Mart.
Further Reading
- Five stocks we like better than Loblaw Companies
- The Risks of Owning Bonds
- Bassett Furniture: Buy Now, Sit Back, and Collect Dividends
- Investing In Preferred Stock vs. Common Stock
- AST SpaceMobile’s Big Win: Shares Soar on New Deal With Verizon
- With Risk Tolerance, One Size Does Not Fit All
- Catch the Next Bitcoin Rally With These 3 ETFs
Receive News & Ratings for Loblaw Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Loblaw Companies and related companies with MarketBeat.com's FREE daily email newsletter.